International Journal of Medical and Pharmaceutical Research
2026, Volume-7, Issue 3 : 1560-1565
Research Article
Results of Masquelet Technique in the Treatment of Tibial Gap Non-Union: A Prospective Study in Lower Assam
 ,
 ,
Received
April 22, 2026
Accepted
May 5, 2026
Published
May 29, 2026
Abstract

Introduction: Infected nonunion of tibia per se is a challenge to treat. Subcutaneous bone causes susceptibility to non-responsive infection, nonunion, fibrosis, sinuses, deformities, shortening and various other sets of problems which are associated with it. Different methods of treatment have been recommended for management of infected nonunion. The first is the “conventional” or classic method. The objectives of the conventional method are to convert an infected and draining nonunion into one that has not drained for several months and to promote healing of the nonunion by bone grafting. This method of treatment often requires one or more years to complete and usually results in stiffness of adjacent joints. The objective of the second i.e. active method is to obtain bony union early and shorten the period of convalescence and preserve motion in the adjacent joints. After restoration of bony continuity, all devitalized and infected bone and soft tissues are removed. Then the fragments are aligned and stabilized, usually by an external fixation device.2

Materials and Methods: The present prospective study was carried out in the Department of Orthopaedics, BMCH, Barpeta. Total of twenty five patients with infected nonunion of tibia of either sex were included in the studyand were treated by Masquelet`s technique. After an informed consent for inclusion into the study, a detailed history was taken including the mode of injury and treatment taken prior to admission. A detailed examination was done to assess the current status of patient including presence of sinuses, knee and ankle range of motion, deformity, limb length discrepancy and neurovascular deficit. Associated injuries were noted, if any. Pus culture was sent. Standard anterio-posterior (AP) and lateral radioraphs of fractured bones were done and fractures were classified according to Paley al17 classification. Patients were subjected to all relevant pre-operative investigations like Hb, BT, CT, Blood urea, Blood sugar, Serum Na+/K+ ,Complete urine examination, ECG, Chest X ray- PA view etc. All the history and clinical findings were documented in the proforma made for this purpose.

Results: Mean gain in length was 3.458 cm (Range; 3-6 cm) as there was no corticotomy done there was no gain in length but the gap was maintained with exact length of bone cement in stage I followed by bone graft in stage II surgeries , which mean value was 3.458 cm (P value = 0.057, by independent t-test, statistically significant). In a study Dendrinos et al28 reported treatment of non-union of the tibia associated with infection in 28 patients. The size of the bone defect that was bridged averaged 6 cm (range, 2 to 13 cm). Magadum et al44 studied 27 men infected nonunion. The mean lengthening achieved was 10 cm.  Thus findings of the present study were comparable to findings in literature.

Conclusion: Masquelet technique has the potential to correct infection, deformity, bone and soft tissue loss and limb length discrepancy simultaneously. It is capable of giving  good to excellent results in infected nonunion of tibia. The functional and radiological results were found to be very satisfactory with Masquelet technique . Duration of fixator period and non union could be improved significantly with  Masquelet technique despite of  bone gap.  A larger prospective study is recommended to further differentiate and give clear cut guidelines in such challenging group of patients.

INTRODUCTION

A nonunion following fracture is a major orthopaedic problem. The presence of infection and bone loss complicates the management of these fractures. Soft tissue damage and periosteal stripping are common in high velocity and open injuries and this can compromise the vascularity to the soft tissues around the fracture. Nonunion is more common when the fractures are open, infected, segmental, with impaired blood supply, comminuted by severe trauma, insecurely fixed, immobilized for an insufficient time, treated by ill-advised open reduction, distracted either by traction or by a plate and screws or of irradiated bone.1

 

Infected nonunion of tibia per se is a challenge to treat. Subcutaneous bone causes susceptibility to non-responsive infection, nonunion, fibrosis, sinuses, deformities, shortening and various other sets of problems which are associated with it. Different methods of treatment have been recommended for management of infected nonunion. The first is the “conventional” or classic method. The objectives of the conventional method are to convert an infected and draining nonunion into one that has not drained for several months and to promote healing of the nonunion by bone grafting. This method of treatment often requires one or more years to complete and usually results in stiffness of adjacent joints. The objective of the second i.e. active method is to obtain bony union early and shorten the period of convalescence and preserve motion in the adjacent joints. After restoration of bony continuity, all devitalized and infected bone and soft tissues are removed. Then the fragments are aligned and stabilized, usually by an external fixation device.2

 

Masquelet technique is a relative new technique used in the management of large bone defects. It is based on two principles or operative stages:

  1. The formation of induction membrane. After bone debridement, the defect is filled with bone cement. The cement is kept for a period of six to eight weeks. This allows the formation of induction membrane.
  2. Cancellous bone grafting. After a period of six to eight weeks, the bone cement is gently removed. The defect is filled with cancellous bone graft. Defects as large as 25cm can be managed using the Masquelet technique.6

 

The first stage in Masquelet’s technique is mechanical: the bone cement provides additional support to the limb and maintains the defect. The primary stability is usually provided by an external fixator. Intramedullary device may also be used as a primary stabilizer. The induction membrane is formed at this stage. The second stage is a biological one. This is the stage that has been studied extensively in a large number of experiments. It has been demonstrated that periosteal flap wrapped around the cancellous bone exerts a protective effect against bone resorption in muscle tissue. The cancellous bone is capable of forming bone even without stress to the bone. But the cancellous bone will resorb if the recipient bed is poorly vascularized.7

 

MATERIALS

The present prospective study was carried out in the Department of Orthopaedics, BMCH, Barpeta. Total of twenty five patients with infected nonunion of tibia of either sex were included in the studyand were treated by Masquelet`s technique.

 

INCLUSION CRITERIA:

  • Patients with infected nonunion of tibia.
  • Patients were considered to have nonunion if:

 

(A) Patient having ununited fracture of tibia with fracture line visible on radiograph.

(B) Gap of <6 cm at the fracture site.

Patients were considered to have infection if patient had discharging sinus at the fracture site or positive swab culture from wound.

 

EXCLUSION CRITERIA:

  • Patients with periarticular nonunion, pathological fractures and fractures associated with bone disorders, presence of any debilitating systemic disease, hormonal disorders were excluded from the study.

 

METHODS:

After an informed consent for inclusion into the study, a detailed history was taken including the mode of injury and treatment taken prior to admission. A detailed examination was done to assess the current status of patient including presence of sinuses, knee and ankle range of motion, deformity, limb length discrepancy and neurovascular deficit. Associated injuries were noted, if any. Pus culture was sent. Standard anterio-posterior (AP) and lateral radioraphs of fractured bones were done and fractures were classified according to Paley al17 classification. Patients were subjected to all relevant pre-operative investigations like Hb, BT, CT, Blood urea, Blood sugar, Serum Na+/K+ ,Complete urine examination, ECG, Chest X ray- PA view etc. All the history and clinical findings were documented in the proforma made for this purpose.

 

PROCEDURE:

Assessment of the clinical and radiological status of the fracture was done. Patients were taken up for surgery as soon as he/she was fit for anaesthesia. Surgeries were performed under anaesthesia. All previously used implants, if any, were removed. A longitudinal or an appropriate incision was given as per need of local soft tissue status. Radical resection of all necrotic tissue including bone was done. Fractures were stabilized monolateral fixator. Three clamps were applied with 8 or 9 tapered threaded pins over rail system.

 

MASQUELET TECHNIQUE:

It is based on two principles i.e two stages of surgery.

The formation of induction membrane: After bone debridement, the defect is filled with bone cement. The cement is kept for a period of six to eight weeks. This allows the formation of induced membrane.

 

Cancellous bone grafting: after a period of six to eight weeks,the cement is gently removed. The defect is filled with cancellous bone graft.

 

Surgical technique

The first step in this technique is the formation of induction membrane. It forms around the bone cement. The membrane serves a very critical function: protection of cancellous bone graft from the body`s immune system. This prevents cancellous bone resorption.

 

The first stage in Masquelet`s technique is mechanical: the bone cement provides additional support to the limb and maintain the defect. The primary stability is usually provided by an external fixator. Intramedullary device may also be used as a primary stabilizer.the induction membrane is formed at this stage.

 

Figure 1 : Clinical photograph showing bone gap after debridement of sclerotic bone

 

Figure 2 : Clinical photograph showing bone cement application after debridement of sclerotic margins

The second stage is a biological one. The second stage of bone grafting is performed 6-8 weeks after the first surgery. The fracture is approached through the previous incision and careful dissection performed down to the defect. The biomembrane encapsulating the cement spacer is carefully incised. Once exposed, the cement spacer is removed and the biomembrane capsule is irrigated to remove any residual debris. With the defect being open,bone graft is placed to fill the entire defect.

 

The defect should be completely filled but not  overstuffed. Once the defect is filled, the biomembrane is closed with absorbable suture. The cancellous bone is capable of forming bone even without stress  to the bone. But the cancellous bone will resorb if the recipient bed is poorly vascularised.

 

The resultant induced membrane was found to be effective in containing the graft materials in situ. It was demonstrated to be an organized pseudosynovial membrane which expressed

  • Bone morphogenic protein 2 (BMP-2)
  • Transforming growth factor-beta (TGF-B)
  • Von Willebrand factor (vWF)
  • Interleukin6 (IL-6) and Interlekin8 (IL-8).

 

POST OPERATIVE PERIOD :

The pin tracts were sealed with Povidone-Iodine soaked gauze pieces. Patients were encouraged to ambulate from the first post-operative day with crutch walking and partial weight bearing. Patients were taught pin care & method of distraction. Exercises were advised to patient to prevent contracture and stiffness. Sutures were removed on the 10-14th post-operative day. Patients were followed up at monthly intervals for a minimum of 6 months or until union whichever is earlier. At each clinical follow up, the patients were assessed clinically and radiologically. Assessment of complications like muscle contractures, joint subluxation, axial deviation, neurological or vascular insult, premature consolidation, delayed consolidation, refracture and pin-site infection was done at each follow up visit and were managed accordingly. Pin tract infections were classified according to Paley’s classification5 in to grade 1, grade 2 and grade 3. Grade 1 and grade 2 infections were grouped together for statistical calculations and labeled as “Superficial pin tract infections”. Grade 3 infections were labeled as “Deep pin tract infections”.

 

Bone results

Excellent

 

 

Union, no infection, deformity < 7°, limb length discrepancy < 2.5 cm.

Good

 

Union + any two of the following:

no infection, deformity < 7°, limb length discrepancy < 2.5 cm.

Fair

 

Union +only one of the following:

no infection, deformity < 7°, limb length discrepancy < 2.5 cm.

Poor

 

Nonunion / refracture / union + infection + deformity > 7° + limb length discrepancy > 2.5 cm.

Functional results

Excellent

 

Active, no limp, minimum stiffness (loss of <15°knee extension/ < 15° dorsiflexion of ankle), no reflex sympathetic dystrophy (RSD), insignificant pain.

Good

 

Active with one or two of the following:

Limp, stiffness, RSD, significant pain.

Fair

 

Active with three or all of the following:

Limp, stiffness, RSD, significant pain.

Poor

 

Inactive (unemployment or inability to return to daily activities

because of injury).

Failure

 

Amputation

 

 

OBSERVATION & RESULTS

Table  1 : Distribution by pus culture

 

 

 

 

 

PUS CULTURE

E. Coli

Count

6

 

% within Group

24.0%

 

Klebsiella

Count

4

 

% within Group

16.0%

 

Staphylococcus

Count

15

 

% within Group

60.0%

 

Total

Count

25

 

% within Group

100.0%

 

Most common infective agent in this study group was Staphylococcus (60 %)

 

Table 2: GAIN IN LENGTH (cm)

 

GAIN IN LENGTH (cm)

Masquelet technique

Mean

3.458

N

12

 

There was no gain in length but the gap was maintained with exact length of bone cement in stage I followed by bone graft in stage II surgeries. which mean value was 3.458 cm (P value = 0.057, by independent t-test, statistically not significant).

 

Table 3: DURATION OF FIXATOR (months)

 

DURATION OF FIXATOR (months)

Masquelet technique

Mean

16.417

N

12

Std. Deviation

1.6214

P value

<0.001

 

Average fixator period was 16.417 months (Range; 13-18 months), (P value <0.001, by independent t-test, extremely statistically significant).

 

Table 4 : Union

 

Union was achieved in 23 patients (92.0%). Two patients (8.0%) had nonunion. P value is <0.05.

 

Table 5: Functional results

 

Functional results were excellent in 11 patients, fair in 10, good in 3 with poor results only in 1 patient (P value = 0.26, by Chi square test).

 

Overall most common infective agent in this study was Staphylococcus (15 patients, 60%) , followed E.Coli (6 patients, 24%) and Klebsiella (4 patients, 16%). Yin et61 al evaluated 66 patients with infected tibial nonunion. The samples that were obtained from purulent drainage or bone at the site of infected nonunion were cultured. Bacterial species grown in culture were Staphylococcus aureus in 47%, Pseudomonas aeruginosa in 16%, Escherichia coli in 13%, Klebsiella in 9%, Enterococcus in 6%, Acinetobacter in 3%, Serratia in 3%, Proteus in 1%, Burkholderia cepacia in 1% and Candida in 1% patients. Siboni et al67 conducted a study on management of septic non union of the tibia by Masquelet technique in which they have found Staphylococcus to be most common association with infection(89%)  Staphylococcus was found to be the most common infective agent in present study as well as in above mentioned studies.

 

Mean gain in length was 3.458 cm (Range; 3-6 cm) as there was no corticotomy done there was no gain in length but the gap was maintained with exact length of bone cement in stage I followed by bone graft in stage II surgeries, which mean value was 3.458 cm (P value = 0.057, by independent t-test, statistically significant). In a study Dendrinos et al28 reported treatment of non-union of the tibia associated with infection in 28 patients. The size of the bone defect that was bridged averaged 6 cm (range, 2 to 13 cm). Magadum et al44 studied 27 men infected nonunion. The mean lengthening achieved was 10 cm.  Thus, findings of the present study were comparable to findings in literature.

 

Average fixator period was16.417 months (Range; 13-18 months), (P value <0.001, by independent t-test, statistically significant).). In a study conducted by Tong et al65 evaluated the effectiveness of Masquelet technique and Ilizarov bone transport in lower extremeties bone defects following post traumatic osteomyelitis, the mean finite fixator time was 10.15 months (range,8-14 months) in group A versus 17.21 months (range, 11-24 months) in group B . The fixator period in Group II patients (16.41 months) was more than Group I patient (10.88 months). The fixator period in our study is comparable to the various studies in the literature.

 

Union was achieved in 23 patients (92%).  Nonunion occurred in 8 % patients. Hosny et al30 reported a union rate of 100 % in a study of 11 patients. Chaddha et al54 reported a union rate of 92%. Other studies33, 43,61 also reported 100 % union rate. Patil et al41 reported union in 39 (95%) out of 41 cases. Siboni et al67 reported a union rate of  17 of the 19 cases (89.0%). Kasha et al68 reported a union rate of 100% in their study. Our results, in terms of union, were comparable with various studies reported in literature.

 

Functional results were Excellent in 11 patients (44 %), good in 10 patients (40 %), (4%) poor functional result. 3 patient (12%) had fair outcome. Functional results of present study were comparable to studies reported in literature.

 

CONCLUSION

 Masquelet technique has the potential to correct infection, deformity, bone and soft tissue loss and limb length discrepancy simultaneously. It is capable of giving good to excellent results in infected nonunion of tibia. The functional and radiological results were found to be very satisfactory with Masquelet technique. Duration of fixator period and non union could be improved significantly with Masquelet technique despite of bone gap.  A larger prospective study is recommended to further differentiate and give clear cut guidelines in such challenging group of patients.

 

REFERENCES

  1. Boyd H, Lipinski SW, Wiley JH. Observations on nonunion of the shafts of long bones, with a statistical analysis of 842 patients. J Bone Joint Surg Am 1961;43:159-68.
  2. Cleveland KB: Delayed union and nonunion of fractures. In: Canale ST, Beaty JH, editors. Campbell’s Operative Orthopaedics,12th Ed. Philadelphia Elsevier Mosby p. 2981-3016.
  3. Pelissier Ph., Masquelet A. C., Bareille R., et al. Induced membrane secrete growth factors including vascular and osteoconductive factors and could stimulate bone regeneration. Journal of Orthopaedic Research 2004; 22: 73 – 79.
  4. Gugala Z, Gogolewski A. Healing of critical-size segmental bone defects in the sheep tibiae using bioresorbable polylactide membranes. Injury, Int. J. Care Injured 2002; 33: 71- 76.
  5. Ring D, Jupiter JB, Gan BS, Israeli R, Yaremchuk MJ. Infected nonunion of the tibia. Clin Orthop Relat Res 1999;369:302-11.
  6. Masquelet AC, Fitoussi F, Begue T, Muller GP. Reconstruction of the long bones by the induced membrane and spongy autograft. InAnnales de chirurgie plastique et esthetique 2000;45(3):346-53.
  7. Pelissier P, Masquelet AC, Bareille R, Pelissier SM, Amedee J. Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone regeneration. J Orthop Res 2004;22:73-9.  
  8. Huffman LK, Harris JG, Suk M. Using the bi-masquelet technique and reamer-irrigator-aspirator for post traumatic foot reconstruction. Foot Ankle Int 2009;30:895-9.
  9. Filipiak J, Krawczyk A, Morasiewicz. Distribution of radiological density in bone regenerate in relation to cyclic displacements of bone fragments. Acta of Bioeng Biomech 2009;11:2-9.
Recommended Articles
International Journal of Medical and Pharmaceutical Research journal thumbnail
Volume-7, Issue 3
Citations
14 Views
20 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
Creative Commons Attribution License Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
facebook twitter linkedin mendeley research-gate
© Copyright | International Journal of Medical and Pharmaceutical Research | All Rights Reserved